Sept 11 (Reuters) - Moderna said on Monday it is collaborating with Immatics to develop cancer vaccines.
Immatics will get $120 million upfront cash as part of the agreement. (Reporting by Christy Santhosh in Bengaluru; Editing by Shounak Dasgupta)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.97 USD | +1.29% | +2.28% | +4.32% |
Sept 11 (Reuters) - Moderna said on Monday it is collaborating with Immatics to develop cancer vaccines.
Immatics will get $120 million upfront cash as part of the agreement. (Reporting by Christy Santhosh in Bengaluru; Editing by Shounak Dasgupta)
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
122.6 USD | +4.47% | +0.36% | 44.96B | ||
10.97 USD | +1.29% | +2.28% | 1.12B | ||
1st Jan change | Capi. | |
---|---|---|
+4.32% | 1.12B | |
+5.10% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.25% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.54% | 16.85B | |
+4.45% | 13.76B | |
+34.95% | 12.46B |